Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats-Reference-Cited by-同舟云学术

Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats

Published:2018-12-08 Issue:3 Volume:10 Page:613-625
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Yin Weiqin¹²^ORCID,Jiang Yongwei³,Xu Shiqing¹,Wang Zai¹,Peng Liang¹,Fang Qing¹,Deng Tingting¹,Zhao Wanni¹,Zhang Wenjian¹,Lou Jinning¹²

Affiliation:

1. Institute of Clinical Medical Sciences China‐Japan Friendship HospitalBeijing China

2. Graduate School of Peking Union Medical College Chinese Academy of Medical Sciences & Peking Union Medical CollegeBeijing China

3. Department of Laboratory Medicine China‐Japan Friendship Hospital Beijing China

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12956

Reference38 articles.

1. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus

2. A complex interplay of factors causes diabetic nephropathy

3. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update

4. Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies

5. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking longevity with GLP-1: A key to turn back the clock?;Maturitas;2024-08

2. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists;Molecular Biology Reports;2024-07-23

3. No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study;Clinical Therapeutics;2024-07

4. Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease;Antioxidants;2024-06-20

5. Vildagliptin Nephroprotective Effect in Rats Model with Cisplatin-Induced Nephrotoxicity;Journal of Contemporary Medical Sciences;2024-02-26